Alphabet Stock Hasn't Been This Cheap Since 2023. Here's What History Says Happens Next.
From a trailing price-to-earnings (P/E) ratio standpoint, Alphabet hasn't been this cheap since the beginning of 2023, when ...
This Tech Giant Is a Stock Buyback Leader. Here's What That Means for Investors.
The argument for owning a stake in this long-leading technology name is even stronger when you look at less-obvious metrics.
eWeek2d
‘Solving All Disease’ Using AI is the Mission of Alphabet’s Isomorphic Labs – Its $600M in Funding Will Help
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Alphabet Is A Massive Cash Flow Machine With An Under-Leveraged Balance Sheet: Analyst
WestPark Capital initiated coverage on Alphabet with a Buy rating and $210 price target. Despite missing Q4 estimates, ...
Mag 7 To Bag 7, But Alphabet Is A Sleeping Giant
See why Alphabet Inc. is a strong buy in 2025 with Google's thriving core businesses, promising growth areas, and an ...
Silicon Canals4d
Alphabet spinout Isomorphic Labs secures €555.4M to further transform drug discovery with AI
Isomorphic Labs was founded to apply artificial intelligence to drug discovery. The company is led by AI researcher Sir Demis Hassabis.